4DMedical (ASX:4DX) secured a deal with the University of Chicago Medicine for the use of its lung imaging products, according to a Monday filing with the Australian bourse.
The contract will allow the academic medical center access to the company's lung imaging suite of products, including its computed tomography-enabled lung ventilation analysis software, the filing said.
Financial terms were not disclosed.
4DMedical's shares gained 1% in recent Monday trade.
Price (AUD): $0.47, Change: $+0.01, Percent Change: +1.08%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。